PVA Materials Patents: Leaders, Trends & White Space 2026
- Filing has declined since its 2017 peak. 306 filings in 2017 fell to 30 by 2026, with the 2022 midpoint of 206 confirming a downward trend rather than a plateau.
- Claim activity is broad, not narrow. Records span eight IPC subclasses from base polymer compositions (C08L, 3,841) through packaging (B65D, 669) and adhesives (C09J, 538), showing PVA claims reach well past resin chemistry into downstream applications.
- The most-cited prior art is decades old. The top-cited records date back to the 1990s and centre on photocrosslinked polymers and water-soluble copolymer films — foundational claims that still shape freedom-to-operate today.
Filing growth compares 2021 (241 records) with 2024 (176) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 5,890 records in scope (CR5), not by the ranked leaders only.
What the PVA patent record shows
Polyvinyl alcohol sits at the intersection of commodity polymer chemistry and specialty formulation. Filings tagged with degree of hydrolysis, water solubility, barrier film, crosslinking and fiber spinning cut across resin composition (C08L), polymer processing (C08J) and addition polymer synthesis (C08F), which means the same molecule shows up in claims aimed at packaging films, textile fibers, coatings and adhesives alike. The dataset covers 5,890 patent families filed between 2015 and 2026, drawn from filings at the EPO, USPTO, CNIPA, JPO, WIPO and Canadian offices.
Filing volume peaked in 2017 and has fallen every year since toward the 2026 data cut-off, though the most recent year is understated because publication typically lags filing by around 18 months. The receiving-office spread — Europe and the United States each above 1,100, China at 841, Japan at 740 — points to a genuinely multi-regional claim base rather than a single home market.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 5,890-family dataset: how filing volume has moved year over year, and which IPC subclasses carry the claim density.
A decade of declining filings
Filings ran from 306 in 2017 down to 30 in 2026 (partial year), with 2022 sitting at 206 — a steady downward slope rather than a cyclical dip, consistent with a maturing claim space rather than an emerging one.
Claims concentrate in base polymer composition, but spread wide
C08L (polymer compositions) and C08J (processing and solutions) dominate, but meaningful volume sits in packaging (B65D), laminates (B32B), coatings (C09D) and adhesives (C09J) — evidence that PVA claim strategy extends deliberately into end-use categories.
Shares are the percentage of the 5,890 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Polyvinyl Alcohol (PVA) Materials and Formulations with Eureka
This page is one run against one query. Ask Eureka your own question about polyvinyl alcohol (pva) materials and formulations and every answer comes back with the patent numbers behind it.
Try EurekaThe prior art still shaping freedom-to-operate
US4478971A — High temperature extruded polyvinyl alcohol monofilament and process for the preparation thereof
The invention discloses a process for high-temperature extrusion of water-soluble PVA monofilament: blending 80-98% PVA resin (number average molecular weight 10,000-200,000, degree of hydrolysis 85-91%) with 2-20% plasticizer selected from hydroxyethers, diols, triols and other polyols, reducing moisture content below 1% and volatile content below 2%, then melt-extruding the blend into monofilament.Filed by Shakespeare Company; granted 1984-10-23 — a much older filing than the bulk of this dataset, and worth checking directly for claim scope before assuming it still constrains current work.
View full filing| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US5508317A | Photocrosslinked polymers | 736 |
| 2 | US6787512B1 | Water-soluble copolymer film packet | 722 |
| 3 | US5849810A | Photocrosslinked polymers | 542 |
| 4 | US5583163A | Photocrosslinked polymers | 524 |
| 5 | US5789464A | Photocrosslinked polymers | 488 |
| 6 | US6166117A | Water-soluble film | 487 |
| 7 | US4528316A | Creping adhesives containing polyvinyl alcohol and cationic polyamide resins | 342 |
| 8 | US6303687B1 | Crosslinked polymers containing salt structures | 337 |
| 9 | US3892905A | Cold water soluble plastic films | 275 |
| 10 | US4524064A | Wound-covering materials | 254 |
Citation counts favour older, foundational filings within this searched corpus — read them as a measure of influence on later claims, not as a signal of current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three patterns stand out once the filing trend, IPC spread and citation data are read together.
Volume has declined for nearly a decade
Peak filing in 2017 was followed by a steady drop through the 2022 midpoint of 206 down to 30 in the most recent (partial) year. That pattern reads as a maturing claim space where core compositions are already staked out, not a market in early growth.
PVA claims extend well past resin chemistry
Beyond the core C08L and C08J subclasses, meaningful filing volume sits in packaging (B65D, 669), laminates (B32B, 608), coatings (C09D, 592) and adhesives (C09J, 538) — a sign that formulation claims are routinely paired with application-specific claims.
Foundational art is old and narrow in topic
The most-cited records cluster around photocrosslinked polymer chemistry and water-soluble copolymer film packets, several from the 1990s. New entrants doing crosslinking or water-soluble film work should check these lineages first.
Joint filing is rare and mostly regional
Co-assignee activity is limited to ten pairs, with the strongest pairings each appearing seven times. That is a low-collaboration field where most assignees file independently rather than through joint ventures or university partnerships.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to polyvinyl alcohol (pva) materials and formulations, with the prior art for and against each one.
| Assignee | Co-assignee | Shared families |
|---|---|---|
| Kuraray Co., Ltd. | University of Liège | 7 |
| Novartis AG (Switzerland) | NOVARTIS PHARM GMBH | 7 |
| Sekisui Chemical Co., Ltd. | Dai Nippon Printing Co., Ltd. | 7 |
| Kuraray Co., Ltd. | Kuraray Fastening Co., Ltd. | 5 |
| Kuraray Co., Ltd. | Kuraray Europe GmbH | 5 |
| Nippon Synthetic Chemical Industry Co., Ltd. | BASF SE | 5 |
| MonoSol, LLC | VERRALL ANDREW P | 5 |
| Kuraray Co., Ltd. | Yamaguchi University | 4 |
Only ten co-assignee pairs appear across 5,890 families, and the strongest pairs each recur seven times — most PVA patent activity is filed solo rather than jointly.
Who holds the ground, and where momentum has stalled
Recent-year filing counts show broad pullback across the named assignees rather than a single company pulling ahead.
Even active filers are pulling back
Mitsubishi Chemical filed only 1 record in the latest year, down 90% year over year — a pattern echoed by other established filers whose latest-year counts have dropped to zero.
Several long-standing filers show no latest-year activity
Kuraray, Nippon Synthetic Chemical, Monosol, Novartis and DuPont all show zero filings in the most recent year in this dataset, which either reflects a genuine pause or the reporting lag typical of the most recent filing year.
Filing strategy is genuinely multi-jurisdictional
With Europe and the US each above 1,100 filings and China and Japan both above 700, assignees active in PVA are clearing claims across all major markets rather than concentrating in one home jurisdiction.
| Assignee | Recent year | YoY |
|---|---|---|
| Mitsubishi Chemical Corporation | 1 | -90% |
| Kuraray Co., Ltd. | 0 | -100% |
| Nippon Synthetic Chemical Industry Co., Ltd. | 0 | — |
| MonoSol, LLC | 0 | -100% |
| Novartis AG (Switzerland) | 0 | — |
| E.I. du Pont de Nemours and Company (USA) | 0 | — |
| The Procter & Gamble Company | 0 | -100% |
| Sekisui Chemical Co., Ltd. | 0 | — |
Where to take this next
The trend and assignee data point to specific next steps depending on whether the goal is freedom-to-operate or new filing.
Check the foundational crosslinking art directly
The most-cited records in this corpus centre on photocrosslinked polymers and water-soluble film packets from the 1990s. Anyone filing new crosslinking or dissolvable-film claims should read these directly rather than rely on citation count alone.
Explore key patentsInvestigate why major filers went to zero
Several established assignees show zero filings in the latest year. Before reading that as market exit, confirm whether it reflects publication lag, a strategic pause, or a genuine shift away from PVA formulation work.
Run an assignee deep-dive in EurekaMap the under-claimed branches against your own R&D
Barrier coatings for non-packaging substrates and enzymatic crosslinking alternatives show thinner filing density than core resin claims. That gap is worth testing against internal formulation work before assuming it is unclaimed.
Search white space in EurekaCommon questions about PVA patents
The dataset's assignee ranking (rendered separately on this page) shows filing concentrated among a handful of established chemical manufacturers, several of which show sharply reduced or zero filings in the most recent year. Rather than a single dominant holder, the picture is a cluster of established players with declining recent activity plus a long tail of smaller filers. Checking both the historical ranking and the recent-year momentum is necessary because a company can hold a large historical portfolio while having effectively stopped filing new PVA claims.
Filings dropped from 306 in 2017 to 30 by 2026, with the 2022 midpoint at 206, indicating a steady decline rather than a temporary dip. This pattern is typical of a technology area where core resin compositions, hydrolysis-degree ranges and basic crosslinking chemistries were staked out earlier, leaving less unclaimed ground for new base filings. It does not mean commercial interest in PVA has disappeared — production and use of PVA in packaging, textiles and coatings continues — only that the pace of new patent claims in this specific claim space has slowed. Note also that the most recent year is always undercounted because publication typically lags filing by about 18 months.
US4478971A, assigned to Shakespeare Company and granted in 1984, claims a process for melt-extruding water-soluble PVA monofilament from a blend of 80-98% PVA resin (specific molecular weight and hydrolysis-degree ranges) with 2-20% plasticizer, after reducing moisture and volatile content to specified thresholds. Given its 1984 grant date, its enforceable term has almost certainly expired, so it functions today as prior art rather than an active blocking patent. It remains relevant as a reference point for anyone patenting new PVA fiber-spinning processes, since later filings in this space are often distinguished from or built on the parameters it disclosed.
C08L (polymer compositions) and C08J (polymer processing and solutions) carry the largest share of records in this dataset, at 3,841 and 2,904 respectively, followed by C08F (addition polymers) at 2,166. But meaningful volume also sits in application-specific subclasses — B65D for containers and packaging, B32B for laminates, C09D for coatings and C09J for adhesives — so a search limited to the core polymer-chemistry subclasses will miss a real share of relevant filings that claim PVA in a specific end use.
Relative to the dense core claims around resin composition and film-forming processes, sub-areas such as biodegradable PVA fiber blends, low-plasticizer monofilament extrusion, barrier coatings applied to non-packaging substrates, enzymatic crosslinking alternatives, and high degree-of-hydrolysis fiber spinning show comparatively thinner filing density. That does not guarantee an idea in these areas is unclaimed, but it does mean the density of blocking prior art is lower than in the core composition and packaging-film branches, making these areas worth a targeted freedom-to-operate search before investing in R&D.
Research Polyvinyl Alcohol (PVA) Materials and Formulations in depth with Eureka
Go past this page: query the whole polyvinyl alcohol (pva) materials and formulations corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.